SNMMI Alzheimer's Association Medicare Decision CMS Beta Amyloid PET Coverage

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer Association have released responses to the draft Medicare decision from the Centers for Medicare and Medicaid Services (CMS) proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Both groups expressed disappointment to the CMS decision, stating that sufficient evidence exists to support immediate coverage, which would change patient management, leading to better health outcomes for patients and assisting families making care decisions.

Researchers have announced the results of a five-year study that shows early fetal echocardiography provides reliable prenatal diagnosis of major congenital heart disease (CHD). First trimester screening looks very promising for detection of heart problems and increases the need for scheduling early and detailed cardiac evaluations.

 

Epsilon Imaging Inc. announced a clinical study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of left ventricle (LV) function. The study, presented at the ASE 2013 Scientific Sessions in Minneapolis, Minn., further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients.

glucoCEST University College London Tumors MRI glucose

A new technique for detecting cancer by imaging the consumption of sugar with magnetic resonance imaging (MRI) has been unveiled by University College London (UCL) scientists. The breakthrough could provide a safer and simpler alternative to standard radioactive techniques and enable radiologists to image tumors in greater detail.

Sectra has recently registered a new Class 1 software medical device, Sectra DoseTrack, with the U.S. Food and Drug Administration (FDA).

Researchers have announced the results of a study which shows that among patients readmitted for congestive heart failure (CHF), a high E/e’ (a measure of elevated left ventricle filling pressure via ultrasound) at admission is significantly associated with higher 30-day readmission rates.  Focusing on lowering elevated E/e’ levels will be important to control healthcare costs and to reduce the high rates of morbidity and mortality in this patient population.

Medical Imaging U.S. Healthcare Overtesting New England Journal of Medicine

Big changes are coming to the U.S. healthcare system — some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign and Affordable Care Act policies are all attempting to curtail overtesting — with computed tomography (CT) scans, magnetic resonance imaging (MRI) and any other screening often ordered unnecessarily — that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.

To help save the lives of injured and ill mountain and Grauer’s gorillas and to sustain their populations in Rwanda, Uganda and the Democratic Republic of Congo, Gorilla Doctors is using the Viamo ultrasound system, donated by Toshiba America Medical Systems Inc. The system is the first in the project’s 26 years to be used on gorillas in the wild, greatly improving the quality of veterinary care.

Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now